Abcam Plc (ABC):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Abcam Plc (ABC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12407
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:40
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Abcam Plc (Abcam) is a supplier of life science research tools for analysis of living cells at molecular level to understand a wide range of disease conditions. The company develops and markets antibodies and other related products. Its product portfolio includes primary antibodies, secondary antibodies, immunoassay kits and reagents, cell and tissue imaging tools, cellular and biochemical assays, proteins and peptides, proteomics tools, agonists, activators, antagonists and inhibitors, lysates, and multiplex miRNA assay. Abcam’s products are used by life science researchers to identify proteins for life sciences and veterinary sciences. The company distributes its products in the Americas, Europe, Asia-Pacific and other countries. Abcam is headquartered in Cambridge, Cambridgeshire, the UK.

Abcam Plc (ABC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Abcam Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Abcam Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Abcam Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Abcam Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Abcam Plc, Medical Devices Deals, 2012 to YTD 2018 10
Abcam Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Abcam Plc, Pharmaceuticals & Healthcare, Deal Details 12
Venture Financing 12
AxioMx Raises US$2 Million In Second Round Of Venture Financing 12
AxioMx Raises US$2 Million In Venture Financing 13
AxioMx Raises Additional US$0.5 Million In Venture Financing 14
Partnerships 15
Abcam Enters into Agreement with Institute Of Molecular And Cell Biology 15
Licensing Agreements 16
Abcam Enters into Licensing Agreement with Roche 16
Abcam Enters into Licensing Agreement with Horizon Discovery 17
Children’s Cancer Institute Enters into Licensing Agreement with Abcam 18
TGR BioSciences Enters Into Licensing Agreement With Abcam 19
Abcam Enters Into Licensing Agreement With Pfizer 20
Equity Offering 21
Abcam Completes Private Placement Of Shares For US$77 Million 21
Acquisition 22
Abcam Acquires AxioMx 22
Abcam Acquires Firefly BioWorks for USD28 Million in Tender Offer 23
Abcam Completes Acquisition Of Epitomics, Rabbit Monoclonal Antibodies Provider, For US$155 Million 24
Abcam Plc – Key Competitors 25
Abcam Plc – Key Employees 26
Abcam Plc – Locations And Subsidiaries 27
Head Office 27
Other Locations & Subsidiaries 27
Recent Developments 29
Financial Announcements 29
Sep 10, 2018: Abcam: Preliminary results 2018 29
Mar 05, 2018: Abcam: Interim results for the six months ended 31 December 2017 31
Sep 11, 2017: Abcam: Double-digit earnings growth enabling investment for sustained future growth 32
Corporate Communications 33
Oct 30, 2018: Abcam appoints Cheri Walker, PhD, as Senior Vice President, Corporate Development 33
Jun 18, 2018: Abcam Appoints Peter Allen As Chairman 34
Nov 15, 2017: ABCAM: Result of AGM and Directorate Change 35
Oct 11, 2017: Abcam: Directorate Change – Chairman 36
Product News 37
Feb 06, 2018: Introducing FirePlex-HT High-throughput Multiplex Immunoassays – Delivering More Data from Precious Samples 37
Other Significant Developments 38
Jul 27, 2017: Abcam: Pre-Close Period Update 38
Mar 06, 2017: Abcam: Interim Results delivering double digit sales growth 39
Appendix 40
Methodology 40
About GlobalData 40
Contact Us 40
Disclaimer 40

List of Tables
Abcam Plc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
Abcam Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Abcam Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Abcam Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Abcam Plc, Deals By Therapy Area, 2012 to YTD 2018 9
Abcam Plc, Medical Devices Deals, 2012 to YTD 2018 10
Abcam Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
AxioMx Raises US$2 Million In Second Round Of Venture Financing 12
AxioMx Raises US$2 Million In Venture Financing 13
AxioMx Raises Additional US$0.5 Million In Venture Financing 14
Abcam Enters into Agreement with Institute Of Molecular And Cell Biology 15
Abcam Enters into Licensing Agreement with Roche 16
Abcam Enters into Licensing Agreement with Horizon Discovery 17
Children’s Cancer Institute Enters into Licensing Agreement with Abcam 18
TGR BioSciences Enters Into Licensing Agreement With Abcam 19
Abcam Enters Into Licensing Agreement With Pfizer 20
Abcam Completes Private Placement Of Shares For US$77 Million 21
Abcam Acquires AxioMx 22
Abcam Acquires Firefly BioWorks for USD28 Million in Tender Offer 23
Abcam Completes Acquisition Of Epitomics, Rabbit Monoclonal Antibodies Provider, For US$155 Million 24
Abcam Plc, Key Competitors 25
Abcam Plc, Key Employees 26
Abcam Plc, Subsidiaries 27

List of Figures
Abcam Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Abcam Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Abcam Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Abcam Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Abcam Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Abcam Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Abcam Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Abcam Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Abcam Plc, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Abcam Plc (ABC):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Box Inc (BOX):企業の財務・戦略的SWOT分析
    Box Inc (BOX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Innate Pharma SA (IPH):企業の財務・戦略的SWOT分析
    Summary Innate Pharma SA (Innate Pharma) is a biotechnology company developing antibodies to treat cancer by harnessing the immune system. It offers Lumoxiti, a CD22-directed immunotoxin for the treatment of relapsed or refractory hairy cell leukemia (HCL). The company is investigating drugs against …
  • Auspex Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Auspex Pharmaceuticals Inc (Auspex), a subsidiary of Teva Pharmaceutical Industries Ltd is a biopharmaceutical company that develops and commercializes novel medicines for the treatment of movement disorders and other rare diseases including orphan diseases. The company offers products for t …
  • Apple Inc:企業の戦略・SWOT・財務分析
    Apple Inc - Strategy, SWOT and Corporate Finance Report Summary Apple Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • GlaxoSmithKline Plc (GSK):企業の財務・戦略的SWOT分析
    GlaxoSmithKline Plc (GSK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • ProteinSimple-製薬・医療分野:企業M&A・提携分析
    Summary ProteinSimple, formerly Cell Biosciences Inc, a subsidiary of Bio Techne Corp, is a medical device company that offers protein analysis solutions. The company offers products such as simple plex systems, simple western systems, micro-flow imaging systems, cIEF and CE-SDS; gel documentation s …
  • Helm AG:企業の戦略・SWOT・財務情報
    Helm AG - Strategy, SWOT and Corporate Finance Report Summary Helm AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, pr …
  • InSphero AG:製薬・医療:M&Aディール及び事業提携情報
    Summary InSphero AG (InSphero) is a biotechnology company that offers production, culture and assessment of organotypic 3D cell culture models. The company’s product portfolio includes microtissues kits, cytotoxicity assay kits, and microtissue spheroids, among others. Its patented 3D cell culture p …
  • CymaBay Therapeutics Inc (CBAY):企業の財務・戦略的SWOT分析
    CymaBay Therapeutics Inc (CBAY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Utah Medical Products Inc (UTMD):企業の財務・戦略的SWOT分析
    Summary Utah Medical Products Inc (Utah Medical) is a medical device company that offers disposable and reusable products. The company offers blood pressure monitoring and blood management, gynecology, urology and electrosurgery, perinatology, respiratory and OEM products. Its blood pressure monitor …
  • JPMorgan Chase & Co (JPM):企業の財務・戦略的SWOT分析
    JPMorgan Chase & Co (JPM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • British Columbia Cancer Agency-製薬・医療分野:企業M&A・提携分析
    Summary British Columbia Cancer Agency (BC Cancer Agency), a subsidiary of Provincial Health Services Authority is a healthcare service center that provides comprehensive cancer control program. The center offers services such as patient assessment, diagnostic and therapy planning, radiation therapy …
  • Freestone Resources Inc (FSNR):企業の財務・戦略的SWOT分析
    Summary Freestone Resources Inc (Freestone Resources) is an oilfield technology company that offers unconventional and conventional oil recovery solutions. The company offers petrozene solvent. Its petrozene solvent offers solutions in operations of tanker sludge, sediment and water, tar residue and …
  • Amneal Pharmaceuticals Inc:企業のM&A・事業提携・投資動向
    Amneal Pharmaceuticals Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Amneal Pharmaceuticals Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • AstraZeneca Plc (AZN):医療機器:M&Aディール及び事業提携情報
    Summary AstraZeneca plc (AstraZeneca) is a biopharmaceutical company that endeavors to discover, produce and commercialize a wide range of prescription drugs. It focuses on therapy areas such as respiratory; cardiovascular and renal and metabolic diseases; and cancer, besides autoimmune, infection a …
  • Interleukin Genetics Inc (ILIU)-医療機器分野:企業M&A・提携分析
    Summary Interleukin Genetics Inc (Interleukin) is a molecular diagnostics company which develops and distributes genetic tests for the personalized health market. Its major genetic tests include ILUSTRA genetic risk test ; cardiovascular risk test; weight management genetic test; bone health genetic …
  • BW Group Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary BW Group Ltd (BW Group) formerly Bergesen Worldwide Limited, is an oil and gas company which provides maritime services. The company offers oil and gas shipping and others related services. It offers environmental technologies, floating gas infrastructure, and deepwater production services. …
  • United Technologies Corp (UTX):企業の財務・戦略的SWOT分析
    United Technologies Corp (UTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • POP Biotechnologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary POP Biotechnologies Inc (POP Biotechnologies) is a biotechnology company that develops and harnesses nano-scale technologies. The company’s product portfolio comprises of NP-01, an encapsulated nanoparticle used to impart systemic drug release; and C36 product, a cobalt indulged nanoparticle …
  • China Petrochemical Corp:企業のM&A・事業提携・投資動向
    China Petrochemical Corp - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's China Petrochemical Corp Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆